269 related articles for article (PubMed ID: 33015987)
1. Prognostic Significance of Thrombomodulin mRNA in High-Grade Soft Tissue Sarcomas after 10 years.
Asanuma K; Nakamura T; Asanuma Y; Okamoto T; Kakimoto T; Yada Y; Hagi T; Kita K; Nakamura K; Matsumine A; Sudo A
Orthop Surg; 2020 Dec; 12(6):1726-1732. PubMed ID: 33015987
[TBL] [Abstract][Full Text] [Related]
2. Serum thrombomodulin as a metastatic and prognostic marker in soft tissue sarcomas.
Asanuma K; Nakamura T; Asanuma Y; Kakimoto T; Yada Y; Hagi T; Kita K; Matsumine A; Sudo A
Cancer Biomark; 2019; 26(2):163-170. PubMed ID: 31356193
[TBL] [Abstract][Full Text] [Related]
3. Semi-Quantitative Calculations of Primary Tumor Metabolic Activity Using F-18 FDG PET/CT as a Predictor of Survival in 92 Patients With High-Grade Bone or Soft Tissue Sarcoma.
Andersen KF; Fuglo HM; Rasmussen SH; Petersen MM; Loft A
Medicine (Baltimore); 2015 Jul; 94(28):e1142. PubMed ID: 26181552
[TBL] [Abstract][Full Text] [Related]
4. A novel splice variant of the stem cell marker LGR5/GPR49 is correlated with the risk of tumor-related death in soft-tissue sarcoma patients.
Rot S; Taubert H; Bache M; Greither T; Würl P; Eckert AW; Schubert J; Vordermark D; Kappler M
BMC Cancer; 2011 Oct; 11():429. PubMed ID: 21978106
[TBL] [Abstract][Full Text] [Related]
5. Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?
Posch F; Leitner L; Bergovec M; Bezan A; Stotz M; Gerger A; Pichler M; Stöger H; Liegl-Atzwanger B; Leithner A; Szkandera J
Clin Orthop Relat Res; 2017 May; 475(5):1427-1435. PubMed ID: 28083752
[TBL] [Abstract][Full Text] [Related]
6. High bad and bcl-xL gene expression and combined bad, bcl-xL, bax and bcl-2 mRNA levels: molecular predictors for survival of stage 2 soft tissue sarcoma patients.
Köhler T; Würl P; Meye A; Lautenschläger C; Bartel F; Borchert S; Bache M; Schmidt H; Holzhausen HJ; Taubert H
Anticancer Res; 2002; 22(3):1553-9. PubMed ID: 12168836
[TBL] [Abstract][Full Text] [Related]
7. Significance of coagulation and fibrinolysis markers for benign and malignant soft tissue tumors.
Asanuma K; Nakamura T; Hagi T; Okamoto T; Kita K; Nakamura K; Matsuyama Y; Yoshida K; Asanuma Y; Sudo A
BMC Cancer; 2021 Apr; 21(1):364. PubMed ID: 33827473
[TBL] [Abstract][Full Text] [Related]
8. The Genomic Grade Index predicts postoperative clinical outcome in patients with soft-tissue sarcoma.
Bertucci F; De Nonneville A; Finetti P; Perrot D; Nilbert M; Italiano A; Le Cesne A; Skubitz KM; Blay JY; Birnbaum D
Ann Oncol; 2018 Feb; 29(2):459-465. PubMed ID: 29069276
[TBL] [Abstract][Full Text] [Related]
9. Low HIF-1α and low EGFR mRNA Expression Significantly Associate with Poor Survival in Soft Tissue Sarcoma Patients; the Proteins React Differently.
Rot S; Taubert H; Bache M; Greither T; Würl P; Holzhausen HJ; Eckert AW; Vordermark D; Kappler M
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30513863
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of mRNA levels of osteopontin splice variants in soft tissue sarcoma patients.
Hahnel A; Wichmann H; Greither T; Kappler M; Würl P; Kotzsch M; Taubert H; Vordermark D; Bache M
BMC Cancer; 2012 Apr; 12():131. PubMed ID: 22471890
[TBL] [Abstract][Full Text] [Related]
11. Soluble programmed death-ligand 1 rather than PD-L1 on tumor cells effectively predicts metastasis and prognosis in soft tissue sarcomas.
Asanuma K; Nakamura T; Hayashi A; Okamoto T; Iino T; Asanuma Y; Hagi T; Kita K; Nakamura K; Sudo A
Sci Rep; 2020 Jun; 10(1):9077. PubMed ID: 32493964
[TBL] [Abstract][Full Text] [Related]
12. Regional variation in the survival of patients with a soft-tissue sarcoma of the extremity and trunk wall under a centralized care system : what has been the impact of national policies in the UK?
Fujiwara T; Evans S; Stevenson J; Tsuda Y; Gregory J; Grimer RJ; Abudu S
Bone Joint J; 2021 Sep; 103-B(9):1541-1549. PubMed ID: 34465152
[TBL] [Abstract][Full Text] [Related]
13. A Population-based Analysis of Lymph Node Metastasis in Extremity Soft Tissue Sarcoma: An Update.
Gusho CA; Fice MP; O'Donoghue CM; Gitelis S; Blank AT
J Surg Res; 2021 Jun; 262():121-129. PubMed ID: 33561723
[TBL] [Abstract][Full Text] [Related]
14. Prognostic role of XTP1/DEPDC1B and SDP35/DEPDC1A in high grade soft-tissue sarcomas.
Pollino S; Benassi MS; Pazzaglia L; Conti A; Bertani N; Righi A; Piccinni-Leopardi M; Picci P; Perris R
Histol Histopathol; 2018 Jun; 33(6):597-608. PubMed ID: 29297565
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of newer prognostic markers for adult soft tissue sarcomas.
Levine EA; Holzmayer T; Bacus S; Mechetner E; Mera R; Bolliger C; Roninson IB; Das Gupta TK
J Clin Oncol; 1997 Oct; 15(10):3249-57. PubMed ID: 9336362
[TBL] [Abstract][Full Text] [Related]
16. Prognostic implications of PD-L1 expression in patients with soft tissue sarcoma.
Kim C; Kim EK; Jung H; Chon HJ; Han JW; Shin KH; Hu H; Kim KS; Choi YD; Kim S; Lee YH; Suh JS; Ahn JB; Chung HC; Noh SH; Rha SY; Kim SH; Kim HS
BMC Cancer; 2016 Jul; 16():434. PubMed ID: 27393385
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of preoperative [18-F] fluorodeoxyglucose (FDG) positron emission tomography (PET) imaging in patients with resectable soft tissue sarcomas.
Schwarzbach MH; Hinz U; Dimitrakopoulou-Strauss A; Willeke F; Cardona S; Mechtersheimer G; Lehnert T; Strauss LG; Herfarth C; Büchler MW
Ann Surg; 2005 Feb; 241(2):286-94. PubMed ID: 15650639
[TBL] [Abstract][Full Text] [Related]
18. Telomerase activity and human telomerase reverse transcriptase mRNA expression are correlated with clinical aggressiveness in soft tissue tumors.
Tomoda R; Seto M; Tsumuki H; Iida K; Yamazaki T; Sonoda J; Matsumine A; Uchida A
Cancer; 2002 Sep; 95(5):1127-33. PubMed ID: 12209700
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of hyperthermic isolated limb perfusion in the treatment of locally recurrent high-grade soft tissue sarcoma of the extremities.
Farzaliyev F; Touma A; Taeger G; Steinau HU; Hardes J; Streitbürger A; Podleska LE
World J Surg Oncol; 2020 Dec; 18(1):332. PubMed ID: 33349267
[TBL] [Abstract][Full Text] [Related]
20. Single nucleotide polymorphism in fibroblast growth factor receptor 4 at codon 388 is associated with prognosis in high-grade soft tissue sarcoma.
Morimoto Y; Ozaki T; Ouchida M; Umehara N; Ohata N; Yoshida A; Shimizu K; Inoue H
Cancer; 2003 Nov; 98(10):2245-50. PubMed ID: 14601095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
